Moderna Says Vaccine Produces Powerful Immune Response in Those 6 Through 11
The results were announced a day before an advisory committee of the Food and Drug Administration is scheduled to review data for the Pfizer-BioNTech vaccine in children 5 through 11.
No comments:
Post a Comment